Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001571049-14-003110
Filing Date
2014-07-22
Accepted
2014-07-21 18:51:18
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K t1401301_10k.htm 10-K 1380824
2 EXHIBIT 10.43 t1401301_ex10-43.htm EX-10.43 32436
3 EXHIBIT 10.51 t1401301_ex10-51.htm EX-10.51 61178
4 EXHIBIT 21.1 t1401301_ex21-1.htm EX-21.1 5846
5 EXHIBIT 23.1 t1401301_ex23-1.htm EX-23.1 2486
6 EXHIBIT 31.1 t1401301_ex31-1.htm EX-31.1 8394
7 EXHIBIT 32.1 t1401301_ex32-1.htm EX-32.1 4790
  Complete submission text file 0001571049-14-003110.txt   8779799

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mrna-20121231.xml EX-101.INS 1214198
9 XBRL SCHEMA FILE mrna-20121231.xsd EX-101.SCH 83617
10 XBRL CALCULATION FILE mrna-20121231_cal.xml EX-101.CAL 45700
11 XBRL DEFINITION FILE mrna-20121231_def.xml EX-101.DEF 279721
12 XBRL LABEL FILE mrna-20121231_lab.xml EX-101.LAB 616373
13 XBRL PRESENTATION FILE mrna-20121231_pre.xml EX-101.PRE 440991
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

EIN.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-13789 | Film No.: 14985382
SIC: 2834 Pharmaceutical Preparations